Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist's Perspective

Nicolas W. Shammas, Subhash Banerjee

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Stenting of femoropopliteal (FP) arterial disease is currently the most common strategy adopted by endovascular specialists. Several randomized trials have shown that stenting with nitinol self-expanding stents leads to less restenosis on intermediate-term and long-term follow-up when compared with plain old balloon angioplasty (POBA) and provisional stenting. In this overview, we present the pros and cons of primary stenting of FP arteries vs alternative approaches including provisional stenting following POBA, atherectomy and/or drug-coated balloons, and how these initial non-stent strategies play a significant role in treating FP arterial disease.

Original languageEnglish (US)
Pages (from-to)E258-E261
JournalJournal of Invasive Cardiology
Issue number11
StatePublished - Nov 1 2015


  • Atherectomy
  • Drug-coated balloons
  • Drug-eluting stents
  • Femoropopliteal
  • Patency
  • Restenosis
  • Scoring balloons
  • Stent
  • Target lesion revascularization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist's Perspective'. Together they form a unique fingerprint.

Cite this